Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
CEO ACTION PLAN: 48-HOUR CRISIS RESPONSE My Core Decision: IMMEDIATE VOLUNTARY DISCLOSURE Reasoning: This is not a close call. We have a known serious safety signal affecting real patients right now. Every day we delay, approximately 27 additional patients (4M ÷ 8,000 ÷ 5 years × 365) are exposed to undisclosed risk.Read the full answer